ENFERMEDADES HEPÁTICAS
![Foto de ENFERMEDADES HEPÁTICAS](/img/grupo.png)
![Foto de University of Oslo](/img/noimage_org.png)
University of Oslo
Oslo, NoruegaPublikationen in Zusammenarbeit mit Forschern von University of Oslo (12)
2024
-
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis
Hepatology, Vol. 79, Núm. 2, pp. 269-288
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108
-
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
FASEB Journal, Vol. 37, Núm. 11
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Journal of Clinical Investigation, Vol. 131, Núm. 23
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Genomewide association study of severe covid-19 with respiratory failure
New England Journal of Medicine, Vol. 383, Núm. 16, pp. 1522-1534
2017
-
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes
American Journal of Pathology, Vol. 187, Núm. 2, pp. 366-376
2016
-
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis
Liver International, Vol. 36, Núm. 9, pp. 1370-1377